Thymosin Beta 500 – 25 mg vial

Thymosin Beta-4 (25 mg vial, subcutaneous injection) is a powerful regenerative peptide that plays a key role in tissue repair, immune modulation, and inflammation control. It promotes cell migration, angiogenesis (new blood vessel formation), and regeneration of injured tissues, making it highly effective in treating muscle tears, ligament injuries, surgical recovery, and even cardiac or neurological repair. Thymosin Beta-4 also helps modulate the immune system by balancing inflammatory cytokines and supporting white blood cell function, which is especially beneficial in chronic inflammation, autoimmune conditions, or immune suppression. The 25 mg dose is typically used in therapeutic or performance-enhancing protocols, either as a loading dose or divided over several injections. At Qeliza, it is often combined with BPC-157, GHK-Cu, or NAD+ to create a synergistic protocol for full-body regeneration and recovery.